CLINICAL TRIALS PROFILE FOR NOVOEIGHT
✉ Email this page to a colleague
All Clinical Trials for NOVOEIGHT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02207218 ↗ | To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan | Completed | Novo Nordisk A/S | 2014-08-04 | This study is conducted in Asia. The aim of this study is to evaluate the safety and efficacy of NovoEight® (recombinant factor VIII) in patients with haemophilia A in Japan in the setting of routine clinical practice. | |
NCT02941354 ↗ | Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A | Completed | Novo Nordisk A/S | Phase 1 | 2016-10-10 | This trial is conducted globally. The aim of this trial is evaluating the pharmacokinetics (the exposure of the trial drug in the body) of NovoEight® (turoctocog alfa) in relation to BMI (body mass index) in subjects with haemophilia A. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NOVOEIGHT
Condition Name
Clinical Trial Locations for NOVOEIGHT
Trials by Country
Clinical Trial Progress for NOVOEIGHT
Clinical Trial Phase
Clinical Trial Sponsors for NOVOEIGHT
Sponsor Name